April 7, 2025

Video

Beyond the Data: The SOUL Trial

12:07

Mamas Mamas, Matthew Cavender, and Michael Blaha discuss the impact of oral semaglutide use for type 2 diabetes patients with ASCVD and/or CKD.

Coronary

clinical cardiology

Clinical Pharma

Diabetes

Michael Blaha

matthew cavender

mamas Mamas

Interview

Advertisement

Latest Videos

08:02

What’s New in the US Guidelines for ACS?

19:46

Beyond the Data: Medical Mission Work

12:07

Beyond the Data: The SOUL Trial

15:24

What's Next for the ABCVM?

05:26

Quick Takes: David Školoudík on the SONOBIRDIE Trial

13:48

Formalizing Interventional Heart Failure Training?

12:41

Quick Takes: Yogesh Reddy on NT-proBNP Thresholds for HFpEF Diagnosis

11:31

ACC 2025 Conference Wrap-Up

06:29

Quick Takes: Marwan Saad on the Clinical Implications of PROTECTED TAVR

08:24

ACC 2025 Day 3 Wrap-Up

14:27

Beyond the Data: Ischemia in Women - The WARRIOR Trial

09:55

ACC 2025 Day 2 Wrap-Up

Partner Content

Explore All

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.